Riskpilot← Back to searchSign inGet full accessBIONORDIKA AS
ASActiveOrg 942855869Gladengveien 3B, 0661 OsloWholesale of chemical products · NACE 4685Est. 198610 employeeswww.bionordikabergman.no
Revenue 2024
NOK 43,5M
-3% vs 2023
EBITDA margin
4.9%
-39% vs 2023
Equity ratio
35.4%
Financial strength
Net profit 2024
NOK 1,8M
-34% vs 2023
| Revenue | NOK 43,5M | -3% |
| EBITDA | NOK 2,1M | -39% |
| Net profit | NOK 1,8M | -34% |
| Total assets | NOK 20,3M | +11% |
| Equity | NOK 7,2M | -2% |
| Employees | 10 | — |
Legal name
BIONORDIKA AS
Org number
942855869
Legal form
Aksjeselskap
NACE code
4685 · Wholesale of chemical products
Founded
11. desember 1986
Share capital
NOK 101 500
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Address
Gladengveien 3B, 0661 Oslo
Website
www.bionordikabergman.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 75 368 | 68 053 | 54 258 | 44 901 | 43 483 |
| Staff expenses | −14 033 | −10 802 | −11 296 | −11 360 | −12 652 |
| EBITDA | 17 216 | 19 792 | 10 926 | 3 517 | 2 148 |
| Depreciation & amort. | −143 | −171 | −172 | −163 | −174 |
| EBIT | 17 074 | 19 620 | 10 754 | 3 354 | 1 974 |
| Net financials | −275 | −115 | 297 | 210 | 380 |
| Profit before tax | 16 799 | 19 505 | 11 051 | 3 564 | 2 354 |
| Tax | 3 705 | 4 309 | 2 446 | 803 | 534 |
| Net profit | 13 094 | 15 197 | 8 605 | 2 762 | 1 820 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 35 941 | 36 402 | 26 660 | 18 240 | 20 322 |
| Equity | 7 304 | 7 500 | 7 605 | 7 367 | 7 187 |
| Long-term debt | 0 | 0 | 193 | 0 | 0 |
| Short-term debt | 28 637 | 28 901 | 18 862 | 10 752 | 11 904 |
| Total debt | 28 637 | 28 901 | 19 054 | 10 752 | 11 904 |
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
20202024
Equity ratio
35.4%
This company
38.2%
Market median
+7% vs market
20202024
Return on equity
25.3%
This company
18.4%
Market median
+38% vs market
20202024
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20202024
Asset turnover
2.14×
This company
1.12×
Market median
+91% vs market
20202024
Debt / equity
1.83×
This company
0.62×
Market median
-195% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HR Chief Executive Officer | Chief Executive Officer | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2025 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2024 – 2025 | |
| Board of Directors | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Addlife Development Ab | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIONORDIKA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Haakon Rivertz Torgersen | Chief Executive Officer | 0 companies |
| Rolf Mattias Bengtsson | Chairman | 0 companies |
| Jussi Sakari Kurittu | Chairman | 0 companies |
| Michael Hartmann | Board of Directors | 0 companies |
| Morten Willemoes Dyrner | Board of Directors | 0 companies |
| Heinrich Preben Biehl | Board of Directors | 0 companies |